Active individuals and everyday people in Orange County are turning to this therapy to recover from sports injuries, repetitive strain, and general wear and tear
On a U-100 insulin syringe, 250 g (0.25 mg) of BPC-157 equals 12.5 units when reconstituted at 5 mg / 2.5 mL (2 mg/mL concentration)
Addressing Bottlenecks When Progress Stalls Rather than pushing the KLOW dose higher, identify the bottleneck and address it with the appropriate solution: Weak results or lack of visible progress Lifestyle factors: adequate protein, vitamin C, copper-zinc balance, and sleep Low-potency vial: KLOW purity and mass
Forward extrapolation can also be attempted
WADA Growth hormone fragments prohibited at all times under S2 on the WADA Prohibited List
Seek medical evaluation if symptoms are rapidly worsening, affecting balance or walking, involving weakness, or not improving after several weeks of supplementation